about
Epithelial defensins impair adenoviral infection: implication for adenovirus-mediated gene therapyThe route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells.Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency interleukin-2Rγ(null) mice engrafted with human peripheral blood mononuclear cells.Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease markerExpression of human beta-defensin-1 promotes differentiation of keratinocytes.A mouse model for ulcerative colitis based on NOD-scid IL2R γnull mice reconstituted with peripheral blood mononuclear cells from affected individuals.NOD-scid IL2R γnull mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways.Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rγ(null) mice engrafted with human peripheral blood mononuclear cellsDifferential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia.Design and validation of a disease network of inflammatory processes in the NSG-UC mouse model.Expression of human beta defensin (HBD-1 and HBD-2) mRNA in nasal epithelia of adult cystic fibrosis patients, healthy individuals, and individuals with acute cold.Budget cuts affecting natural history.Targeting ulcerative colitis by suppressing glucose uptake with ritonavirExpression of anchorin CII, a collagen-binding protein of the annexin family, in the developing chick embryoAnchorin Cll sequence now correctedCD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis.Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitisThe Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ null Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Tr
P50
Q28142767-1C3C341B-54F2-457F-9806-C99BE513D6B5Q38224933-77C02267-3367-43BC-9DD6-F7917327A356Q39168573-B25DC029-EABE-4372-9410-4B158850AA24Q39220077-0107CE0E-7242-46B1-B082-1A6B0EF38F3AQ40788529-8EBCED15-36DC-45DB-82E9-AF09450434CFQ41285453-65C039D6-BDB4-4BCE-91A5-EE01AA3E0DA4Q41768955-CCAF3FFA-31F2-4A5A-8307-1160B4D4E8FAQ42426996-86DEBDBF-375B-403A-8EFA-5865074CFF51Q47662658-71DA2E0D-1430-4D5B-BA6D-9D79C15B9307Q48340870-D2592408-1D73-421C-94B1-02F8452F842DQ51727354-3DBBC829-0BE8-42B3-9A0D-6E276610E944Q53321435-EDD93196-D67D-4124-8319-C8D56AC863C3Q57462248-DCC275E5-2DF2-414F-B075-F67DF512DEE3Q61163878-FC2EC822-F4E5-4567-B1B0-C13C1FAA868FQ61163881-F545E80F-DF25-4920-955F-586642EA84BEQ64979587-8B568AB7-D7B2-4568-8B2A-D6652BB55820Q89679289-1422C14F-A5A0-4CDE-A05F-56394E58B1FBQ91546873-C852A010-E0BE-4B27-94AE-3FF9ED2FC4F3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roswitha Gropp
@ast
Roswitha Gropp
@en
Roswitha Gropp
@es
Roswitha Gropp
@nl
Roswitha Gropp
@sl
type
label
Roswitha Gropp
@ast
Roswitha Gropp
@en
Roswitha Gropp
@es
Roswitha Gropp
@nl
Roswitha Gropp
@sl
prefLabel
Roswitha Gropp
@ast
Roswitha Gropp
@en
Roswitha Gropp
@es
Roswitha Gropp
@nl
Roswitha Gropp
@sl
P106
P21
P31
P496
0000-0003-4756-261X